Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « AbsEn.i » - entrée « cardiovascular »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
cardiotoxicity < cardiovascular < cardioversion  Facettes :

List of bibliographic references indexed by cardiovascular

Number of relevant bibliographic references: 77.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000097 (2021) Jack Cook [États-Unis] ; Milton L. Pressler [États-Unis] ; Bharat Damle [États-Unis] ; Demissie Alemayehu [États-Unis] ; Charles A. Knirsch [États-Unis]The Weight of Evidence From Electrophysiology, Observational, and Cardiovascular End Point Studies Demonstrates the Safety of Azithromycin.
000166 (2021) Giulia Fiscon [Italie] ; Federica Conte [Italie] ; Lorenzo Farina [Italie] ; Paola Paci [Italie]SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19.
000170 (2021) Filipa Silva [Portugal] ; Ana Cipriano [Portugal] ; Hugo Cruz [Portugal] ; Joana Tavares [Portugal] ; Joana Fragoso [Portugal] ; Jorge Malheiro [Portugal] ; Manuela Almeida [Portugal] ; La Salete Martins [Portugal] ; Miguel Abreu [Portugal] ; Sofia Pedroso [Portugal] ; Leonídio Dias [Portugal] ; Ant Nio Castro Henriques [Portugal]SARS-CoV-2 infection in kidney transplant recipients: Early report of five cases.
000175 (2021) Okechukwu S. Ogah [Nigeria] ; Ejiroghene M. Umuerri ; Adewole Adebiyi [Nigeria] ; Olanike A. Orimolade [Nigeria] ; Mahmoud U. Sani ; Dike B. Ojji ; Amam C. Mbakwem ; Simon Stewart ; Karen SliwaSARS-CoV 2 Infection (Covid-19) and Cardiovascular Disease in Africa: Health Care and Socio-Economic Implications.
000438 (2021) Bugra Han Egeli [États-Unis] ; Jeffrey A. Sparks [États-Unis] ; Alfred H J. Kim [États-Unis] ; Jean W. Liew [États-Unis]Hydroxychloroquine for the treatment of COVID-19 and its potential cardiovascular toxicity: Hero or villain?
000571 (2021) Mukesh Kumar [Inde] ; Jitender Madan [Inde] ; Rupinder Kaur Sodhi [Inde] ; Shashi Bala Singh [Inde] ; Anju Katyal [Inde]Decoding the silent walk of COVID-19: Halting its spread using old bullets.
000653 (2021) Adam Goldman [Israël] ; David Bomze [Israël, Suisse] ; Rachel Dankner [Israël] ; Hanoch Hod [Israël] ; Tomer Meirson [Israël] ; Ben Boursi [Israël, États-Unis] ; Elad Maor [Israël]Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre-COVID-19 reports.
000654 (2021) Azita Hajhossein Talasaz [Iran] ; Hessam Kakavand [Iran] ; Benjamin Van Tassell [États-Unis] ; Maryam Aghakouchakzadeh [Iran] ; Parham Sadeghipour [Iran] ; Steven Dunn [États-Unis] ; Babak Geraiely [Iran]Cardiovascular Complications of COVID-19: Pharmacotherapy Perspective.
000668 (2021) Saad I. Mallah [Oman] ; Omar K. Ghorab ; Sabrina Al-Salmi ; Omar S. Abdellatif [Canada] ; Tharmegan Tharmaratnam [Irlande (pays)] ; Mina Amin Iskandar ; Jessica Atef Nassef Sefen ; Pardeep Sidhu ; Bassam Atallah [Émirats arabes unis, États-Unis] ; Rania El-Lababidi [Émirats arabes unis] ; Manaf Al-Qahtani [Oman]COVID-19: breaking down a global health crisis.
000674 (2021) Hussain Ahmed Raza [Pakistan] ; Javeria Tariq [Pakistan] ; Vikas Agarwal [Inde] ; Latika Gupta [Inde]COVID-19, hydroxychloroquine and sudden cardiac death: implications for clinical practice in patients with rheumatic diseases.
000686 (2021) Carmen Guadalupe Rodriguez-Gonzalez [Espagne] ; Esther Chamorro-De-Vega [Espagne] ; Maricela Valerio [Espagne] ; Miguel Angel Amor-Garcia [Espagne] ; Francisco Tejerina [Espagne] ; Milagros Sancho-Gonzalez [Espagne] ; Alvaro Narrillos-Moraza [Espagne] ; Alvaro Gimenez-Manzorro [Espagne] ; Silvia Manrique-Rodriguez [Espagne] ; Marina Machado [Espagne] ; Maria Olmedo [Espagne] ; Vicente Escudero-Vilaplana [Espagne] ; Cristina Villanueva-Bueno [Espagne] ; Beatriz Torroba-Sanz [Espagne] ; Alejandra Melgarejo-Ortu O [Espagne] ; Juan Vicente-Valor [Espagne] ; Ana Herranz [Espagne] ; Emilio Bouza [Espagne] ; Patricia Mu Oz [Espagne] ; Maria Sanjurjo [Espagne]COVID-19 in hospitalised patients in Spain: a cohort study in Madrid.
000733 (2021) Sherif Sultan [Irlande (pays)] ; Yogesh Acharya [Irlande (pays)]Antimalarial and cytotoxic drugs on COVID-19 and the cardiovascular burden: Literature review and lessons to be learned.
000741 (2021) Álvaro Réa-Neto [Brésil] ; Rafaella Stradiotto Bernardelli [Brésil] ; Bruna Martins Dzivielevski Câmara [Brésil] ; Fernanda Baeumle Reese [Brésil] ; Marcos Vinicius Oliveira Queiroga [Brésil] ; Mirella Cristine Oliveira [Brésil]An open-label randomized controlled trial evaluating the efficacy of chloroquine/hydroxychloroquine in severe COVID-19 patients.
000753 (2021) Viral D. Patel [Inde] ; Khushbu H. Patel [États-Unis] ; Dhairya A. Lakhani [États-Unis] ; Rupak Desai [États-Unis] ; Deep Mehta [États-Unis] ; Priyank Mody [Inde] ; Sumit Pruthi [États-Unis]Acute pericarditis in a patient with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a case report and review of the literature on SARS-CoV-2 cardiological manifestations.
000754 (2021) Setareh Mamishi [Iran] ; Ameneh Navaeian [Iran] ; Reza Shabanian [Iran]Acute aortic dissection in a patient with Williams syndrome infected by COVID-19.
000802 (2020) William H. Frishman [États-Unis]The 11th Trial of a Cardiovascular Clinical Trialist: Coronavirus-2: Part 2.
000805 (2020) Naeem A. Alshoaibi [Arabie saoudite] ; Khadijah Maghrabi [Arabie saoudite] ; Haitham Alanazi [Arabie saoudite] ; Mousa Al Harbi [Arabie saoudite] ; Saleh Alghamdi [Arabie saoudite]Saudi Heart Rhythm Society Task Force on Management of Potential Arrhythmogenicity Associated with Pharmacotherapy for COVID-19.
000810 (2020) Aditya Kapoor [Inde] ; Ulhas Pandurangi [Inde] ; Vanita Arora [Inde] ; Anoop Gupta [Inde] ; Aparna Jaswal [Inde] ; Ashish Nabar [Inde] ; Ajay Naik [Inde] ; Nitish Naik [Inde] ; Narayanan Namboodiri Kk [Inde] ; Amit Vora [Inde] ; Rakesh Yadav [Inde] ; Anil Saxena [Inde]Reply to letters regarding our paper "Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Societyˮ.
000850 (2020) Aditya Kapoor [Inde] ; Ulhas Pandurangi [Inde] ; Vanita Arora [Inde] ; Anoop Gupta [Inde] ; Aparna Jaswal [Inde] ; Ashish Nabar [Inde] ; Ajay Naik [Inde] ; Nitish Naik [Inde] ; Narayanan Namboodiri [Inde] ; Amit Vora [Inde] ; Rakesh Yadav [Inde] ; Anil Saxena [Inde]Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Society.
000851 (2020) P. Conti [Italie] ; A. Younes [Italie]Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection.
000934 (2020) Ezequiel J. Zaidel [Oman] ; Fernando S. Wyss Quintana ; Álvaro Sosa Liprandi ; Iván Mendoza ; Manlio F. Márquez ; Elaine Nu Ez ; Marcia Barbosa ; Adrián Baranchuk[Hydroxychloroquine. Cardiology's viewpoint in times of coronavirus pandemic].

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "cardiovascular" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "cardiovascular" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    cardiovascular
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021